BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20047096)

  • 1. Blimp-1 is a tumor suppressor gene in lymphoid malignancies.
    Hangaishi A; Kurokawa M
    Int J Hematol; 2010 Jan; 91(1):46-53. PubMed ID: 20047096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.
    Tam W; Gomez M; Chadburn A; Lee JW; Chan WC; Knowles DM
    Blood; 2006 May; 107(10):4090-100. PubMed ID: 16424392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.
    Xia Y; Xu-Monette ZY; Tzankov A; Li X; Manyam GC; Murty V; Bhagat G; Zhang S; Pasqualucci L; Visco C; Dybkaer K; Chiu A; Orazi A; Zu Y; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Westin J; Fowler N; Miranda RN; Ok CY; Li Y; Li J; Medeiros LJ; Young KH
    Leukemia; 2017 Mar; 31(3):625-636. PubMed ID: 27568520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.
    Pasqualucci L; Compagno M; Houldsworth J; Monti S; Grunn A; Nandula SV; Aster JC; Murty VV; Shipp MA; Dalla-Favera R
    J Exp Med; 2006 Feb; 203(2):311-7. PubMed ID: 16492805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.
    Boi M; Zucca E; Inghirami G; Bertoni F
    Leuk Lymphoma; 2015 May; 56(5):1223-8. PubMed ID: 25115512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.
    Nie K; Gomez M; Landgraf P; Garcia JF; Liu Y; Tan LH; Chadburn A; Tuschl T; Knowles DM; Tam W
    Am J Pathol; 2008 Jul; 173(1):242-52. PubMed ID: 18583325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.
    Györy I; Fejér G; Ghosh N; Seto E; Wright KL
    J Immunol; 2003 Mar; 170(6):3125-33. PubMed ID: 12626569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
    [No Abstract]   [Full Text] [Related]  

  • 9. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
    Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
    Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10.
    Mock BA; Liu L; LePaslier D; Huang S
    Genomics; 1996 Oct; 37(1):24-8. PubMed ID: 8921366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells.
    Wang WF; Yan L; Liu Z; Liu LX; Lin J; Liu ZY; Chen XP; Zhang W; Xu ZZ; Shi T; Li JM; Zhao YL; Meng G; Xia Y; Li JY; Zhu J
    Nat Commun; 2017 Aug; 8(1):363. PubMed ID: 28842558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells.
    Desai S; Bolick SC; Maurin M; Wright KL
    J Immunol; 2009 Nov; 183(9):5778-87. PubMed ID: 19828640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.
    Garcia JF; Roncador G; García JF; Sánz AI; Maestre L; Lucas E; Montes-Moreno S; Fernandez Victoria R; Martinez-Torrecuadrara JL; Marafioti T; Mason DY; Piris MA
    Haematologica; 2006 Apr; 91(4):467-74. PubMed ID: 16585013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal differentiation of lymphocytes depends on Blimp-1.
    Kallies A; Nutt SL
    Curr Opin Immunol; 2007 Apr; 19(2):156-62. PubMed ID: 17291741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.
    Ren B; Chee KJ; Kim TH; Maniatis T
    Genes Dev; 1999 Jan; 13(1):125-37. PubMed ID: 9887105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into Blimp-1 in T lymphocytes: a divergent regulator of cell destiny and effector function.
    Fu SH; Yeh LT; Chu CC; Yen BL; Sytwu HK
    J Biomed Sci; 2017 Jul; 24(1):49. PubMed ID: 28732506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation and functions of Blimp-1 in T and B lymphocytes.
    Martins G; Calame K
    Annu Rev Immunol; 2008; 26():133-69. PubMed ID: 18370921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.
    Zhang T; Ma J; Nie K; Yan J; Liu Y; Bacchi CE; Queiroga EM; Gualco G; Sample JT; Orazi A; Knowles DM; Tam W
    Blood Cancer J; 2014 Nov; 4(11):e261. PubMed ID: 25382611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blimp-1/PRDM1 regulates the transcription of human CS1 (SLAMF7) gene in NK and B cells.
    Kim JR; Mathew SO; Mathew PA
    Immunobiology; 2016 Jan; 221(1):31-9. PubMed ID: 26310579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.